CICC Has Second Close of Biomedical Fund at $648 Million

CICC Capital announced its RMB biomedical private equity fund, called CICC Qide, has raised $648 million as of the second closing. In February of 2020, CICC announced the first close with $247 million. The fund has already invested in over 20 companies, with several portfolio companies now starting the IPO process. CICC Capital, a platform for Beijing 's China International Capital Corporation, manages RMB and USD funds that are aimed at venture capital, growth, buyout, fund of funds and distressed opportunities. More details.... Share this with colleagues: // //